Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - TOTAL LIABILITIES
Total Liabilities GERN - Geron Corporation
146 M
LAST VALUE
21.11%
2 YEAR CAGR
80.86%
5 YEAR CAGR
34.42%
10 YEAR CAGR